Geneva, Aug. 17 -- International Clinical Trials Registry received information related to the study (ISRCTN31929591) titled 'Omeprazole for babies born early or full-term, who are experiencing reflux' on Aug. 10.
Study Type: Interventional
Study Design:
Allocation: Randomized controlled trial
Masking: Blinded (masking used)
Control: Placebo
Assignment: Parallel
Purpose: Treatment, Safety
Primary Sponsor: University Hospital Southampton NHS Foundation Trust
Condition:
Gastro-oesophageal reflux
Digestive System
Intervention:
Eligible infants will be randomised in a 1:1 ratio to receive omeprazole or matched placebo after eligibility confirmation and parent/caregiver informed consent. Randomisation will be carried out by delegated ...